{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:28:16Z","timestamp":1784366896918,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study explored the correlation between Hemoglobin A1c (HbA1c) and intraocular inflammatory cytokines in proliferative diabetic retinopathy (PDR) patients, aiming to provide evidence for PDR prevention and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional study involving 100 patients and 100 eyes diagnosed with PDR. All patients were collected demographic characteristics, HbA1c, and history of chronic diseases at baseline. Aqueous humor samples of patients were obtained during the intraocular surgery. Then 10 cytokines were assessed using the Cytometric Beads Array (CBA) technique. The relationships between HbA1c and each inflammatory factor were further tested by restricted cubic splines (RCS) in the logistic model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A U-shaped curve was found between IL-6 (interleukin-6) and HbA1c (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0001). HbA1c was negatively associated with IL-6 when below 8.31%. There was also a U-shaped exposure-response relationship between vascular endothelial growth factor (VEGF) and HbA1c (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0211), with the lowest VEGF levels observed at an HbA1c of 6.72%. A J-shaped curve was observed in the relationship between IL-8 (interleukin-8) and HbA1c (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0061). When HbA1c exceeded 8.23%, IL-8 exhibited a significant upward trend. Monocyte chemoattractant protein-1 (MCP-1) shows a positive linear relationship with HbA1c (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0036). No significant differences were found between other cytokines and HbA1c.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study identified the correlation between HbA1c and intraocular inflammation in PDR, characterized by U-shaped relationships with IL-6 and VEGF, a J-shaped relationship with IL-8, and a linear relationship with MCP-1. These findings advocated for a nuanced approach to glycemic management. However, longitudinal studies are still needed to determine whether HbA1c fluctuations directly drive cytokine changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-025-00732-y","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:27:08Z","timestamp":1761121628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The association between glycated hemoglobin and intraocular inflammatory factors in patients with proliferative diabetic retinopathy"],"prefix":"10.1186","volume":"11","author":[{"given":"Jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6349-9685","authenticated-orcid":false,"given":"Jinping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"8","key":"732_CR1","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/jdi.13480","volume":"12","author":"KY Lin","year":"2021","unstructured":"Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322\u201325.","journal-title":"J Diabetes InvestIg"},{"key":"732_CR2","unstructured":"World Health Organization. World report on vision. Geneva, Switzerland: World Health Organization. 2019. https:\/\/icoph.org\/advocacy\/world-report-on-vision. Accessed 29 May 2025."},{"key":"732_CR3","doi-asserted-by":"crossref","unstructured":"Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018;19(6).","DOI":"10.3390\/ijms19061816"},{"issue":"1","key":"732_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12886-023-03118-6","volume":"23","author":"H Li","year":"2023","unstructured":"Li H, Liu X, Zhong H, Fang J, Li X, Shi R, Yu Q. Research progress on the pathogenesis of diabetic retinopathy. BMC Ophthalmol. 2023;23(1):372.","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"732_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3949\/ccjm.91a.24028","volume":"91","author":"DD Chong","year":"2024","unstructured":"Chong DD, Das N, Singh RP. Diabetic retinopathy: Screening, prevention, and treatment. Cleve Clin J Med. 2024;91(8):503\u201310.","journal-title":"Cleve Clin J Med"},{"issue":"5","key":"732_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","volume":"30","author":"J Tang","year":"2011","unstructured":"Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011;30(5):343\u201358.","journal-title":"Prog Retin Eye Res"},{"issue":"15","key":"732_CR7","doi-asserted-by":"publisher","first-page":"e2004433","DOI":"10.1002\/advs.202004433","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Cytokines: from clinical significance to quantification. Adv Sci (Weinh). 2021;8(15):e2004433.","journal-title":"Adv Sci (Weinh)"},{"key":"732_CR8","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1046\/j.1523-1755.2000.07718.x","volume":"77","author":"LP Aiello","year":"2000","unstructured":"Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl. 2000;77:S113\u2013119.","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"732_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1074\/jbc.271.2.736","volume":"271","author":"T Cohen","year":"1996","unstructured":"Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 1996;271(2):736\u201341.","journal-title":"J Biol Chem"},{"key":"732_CR10","doi-asserted-by":"crossref","unstructured":"Ulhaq ZS, Soraya GV, Budu WLR. The role of IL-6-174 G\/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis. Sci Rep. 2020;10(1):17453.","DOI":"10.1038\/s41598-020-74203-9"},{"issue":"6","key":"732_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1464-5491.2005.01538.x","volume":"22","author":"C Hern\u00e1ndez","year":"2005","unstructured":"Hern\u00e1ndez C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Sim\u00f3 R. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabet Med. 2005;22(6):719\u201322.","journal-title":"Diabet Med"},{"issue":"9","key":"732_CR12","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2337\/dc22-2521","volume":"46","author":"R Sim\u00f3","year":"2023","unstructured":"Sim\u00f3 R, Franch-Nadal J, Vlacho B, Real J, Amado E, Flores J, et al. Rapid reduction of HbA1c and early worsening of diabetic retinopathy: a real-world population-based study in subjects with type 2 diabetes. Diabetes Care. 2023;46(9):1633\u201339.","journal-title":"Diabetes Care"},{"issue":"1","key":"732_CR13","doi-asserted-by":"publisher","first-page":"108380","DOI":"10.1016\/j.jdiacomp.2022.108380","volume":"37","author":"Y Xu","year":"2023","unstructured":"Xu Y, Hou H, Zhao L. The role of VCAM-1 in diabetic retinopathy: a systematic review and meta-analysis. J Diabetes Complications. 2023;37(1):108380.","journal-title":"J Diabetes Complications"},{"issue":"2","key":"732_CR14","first-page":"159","volume":"24","author":"S Mitrovi\u0107","year":"2016","unstructured":"Mitrovi\u0107 S, Kelava T, \u0160u\u0107ur A, Gr\u010devi\u0107 D. Levels of selected aqueous humor mediators (IL-10, IL-17, CCL2, VEGF, FasL) in diabetic cataract. Ocul Immunol Inflamm. 2016;24(2):159\u201366.","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"732_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/08820538.2020.1755320","volume":"35","author":"K Cvitkovic","year":"2020","unstructured":"Cvitkovic K, Sesar A, Sesar I, Pusic-Sesar A, Pejic R, Kelava T, Sucur A, Cavar I. Concentrations of selected cytokines and vascular endothelial growth factor in aqueous humor and serum of diabetic patients. Semin Ophthalmol. 2020;35(2):126\u201333.","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"732_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12886-023-03192-w","volume":"23","author":"AR Gomaa","year":"2023","unstructured":"Gomaa AR, Bedda AM, ElGoweini HF, Taleb RSZ, Saleh AMA. Study of aqueous humour inflammatory mediators\u2019 levels in a cohort of Egyptian patients with diabetic macular oedema. BMC Ophthalmol. 2023;23(1):456.","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"732_CR17","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1007\/s00417-021-05285-y","volume":"259","author":"E Midena","year":"2021","unstructured":"Midena E, Frizziero L, Midena G, Pilotto E. Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy. Graefes Arch Clin Exp ophthalmol. 2021;259(12):3549\u201360.","journal-title":"Graefes Arch Clin Exp ophthalmol"},{"issue":"1","key":"732_CR18","doi-asserted-by":"publisher","first-page":"2413920","DOI":"10.1080\/07853890.2024.2413920","volume":"56","author":"H Guo","year":"2024","unstructured":"Guo H, Han F, Qu JR, Pan CQ, Sun B, Chen LM. Scoring and validation of a simple model for predicting diabetic retinopathy in patients with type 2 diabetes based on a meta-analysis approach of 21 cohorts. Ann Med. 2024;56(1):2413920.","journal-title":"Ann Med"},{"issue":"9","key":"732_CR19","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2337\/dc22-2521","volume":"46","author":"R Sim\u00f3","year":"2023","unstructured":"Sim\u00f3 R, Franch-Nadal J, Vlacho B, Real J, Amado E, Flores J, Mata-Cases M, Ortega E, Rigla M, Vall\u00e9s JA, et al. Rapid reduction of HbA1c and early worsening of diabetic retinopathy: a real-world population-based study in subjects with type 2 diabetes. Diabetes Care. 2023;46(9):1633\u201339.","journal-title":"Diabetes Care"},{"key":"732_CR20","doi-asserted-by":"crossref","unstructured":"International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes Res Clin Pr. 2014;104(1):1\u201352.","DOI":"10.1016\/j.diabres.2012.10.001"},{"issue":"1","key":"732_CR21","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1038\/s41598-021-84150-8","volume":"11","author":"HU Kim","year":"2021","unstructured":"Kim HU, Park SP, Kim YK. Long-term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes. Sci Rep. 2021;11(1):4731.","journal-title":"Sci Rep"},{"issue":"4","key":"732_CR22","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/dom.13172","volume":"20","author":"T Vilsb\u00f8ll","year":"2018","unstructured":"Vilsb\u00f8ll T, Bain SC, Leiter LA, Lingvay I, Matthews D, Sim\u00f3 R, Helmark IC, Wijayasinghe N, Larsen M. Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy. Diabetes Obes Metab. 2018;20(4):889\u201397.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"732_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2337\/dc20-1815","volume":"44","author":"MA Bethel","year":"2021","unstructured":"Bethel MA, Diaz R, Castellana N, Bhattacharya I, Gerstein HC, Lakshmanan MC. HbA(1c) change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: a meta-analysis and meta-regression. Diabetes Care. 2021;44(1):290\u201396.","journal-title":"Diabetes Care"},{"key":"732_CR24","first-page":"185","volume":"6","author":"N Baharivand","year":"2012","unstructured":"Baharivand N, Zarghami N, Panahi F, Dokht Ghafari MY, Mahdavi Fard A, Mohajeri A. Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy. Clin Ophthalmol. 2012;6:185\u201391.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"732_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabet.2017.10.014","volume":"44","author":"S Feldman-Billard","year":"2018","unstructured":"Feldman-Billard S, Larger \u00c9, Massin P. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes. Diabetes Metab. 2018;44(1):4\u201314.","journal-title":"Diabetes Metab"},{"issue":"31","key":"732_CR26","doi-asserted-by":"publisher","first-page":"27975","DOI":"10.1074\/jbc.M204152200","volume":"277","author":"C Treins","year":"2002","unstructured":"Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase\/target of rapamycin-dependent signaling pathway. J Biol Chem. 2002;277(31):27975\u201381.","journal-title":"J Biol Chem"},{"issue":"2","key":"732_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10517-021-05191-7","volume":"171","author":"MA Darenskaya","year":"2021","unstructured":"Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: Pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull Exp Biol Med. 2021;171(2):179\u201389.","journal-title":"Bull Exp Biol Med"},{"key":"732_CR28","doi-asserted-by":"crossref","unstructured":"Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12(4).","DOI":"10.3390\/biom12040542"},{"issue":"11","key":"732_CR29","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","volume":"83","author":"A Bierhaus","year":"2005","unstructured":"Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005;83(11):876\u201386.","journal-title":"J Mol Med (Berl)"},{"issue":"10","key":"732_CR30","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1172\/JCI129188","volume":"129","author":"LI Hudish","year":"2019","unstructured":"Hudish LI, Reusch JE. Sussel L. \u03b2 cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Invest. 2019;129(10):4001\u201308.","journal-title":"J. Clin Invest"},{"issue":"2","key":"732_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/1120672120910375","volume":"31","author":"N Gomel","year":"2021","unstructured":"Gomel N, Barequet IS, Lipsky L, Bourla N, Einan-Lifshitz A. The effect of the glycemic control on the aqueous humor glucose levels in diabetic patients undergoing elective cataract surgery. Eur J Ophthalmol. 2021;31(2):415\u201321.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"732_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0006-291X(03)00712-5","volume":"305","author":"H Takaishi","year":"2003","unstructured":"Takaishi H, Taniguchi T, Takahashi A, Ishikawa Y, Yokoyama M. High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells. Biochem Biophys Res Commun. 2003;305(1):122\u201328.","journal-title":"Biochem Biophys Res Commun"},{"key":"732_CR33","first-page":"1906","volume":"15","author":"BT Ozturk","year":"2009","unstructured":"Ozturk BT, Bozkurt B, Kerimoglu H, Okka M, Kamis U, Gunduz K. Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. Mol Vis. 2009;15:1906\u201314.","journal-title":"Mol Vis"},{"key":"732_CR34","first-page":"637","volume":"14","author":"R Maier","year":"2008","unstructured":"Maier R, Weger M, Haller-Schober EM, El-Shabrawi Y, Wedrich A, Theisl A, Aigner R, Barth A, Haas A. Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients. Mol Vis. 2008;14:637\u201343.","journal-title":"Mol Vis"},{"issue":"1","key":"732_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.diabres.2009.01.012","volume":"84","author":"J Adamiec-Mroczek","year":"2009","unstructured":"Adamiec-Mroczek J, Oficjalska-M\u0142y\u0144czak J, Misiuk-Hoj\u0142o M. Proliferative diabetic retinopathy-the influence of diabetes control on the activation of the intraocular molecule system. Diabetes Res Clin Pract. 2009;84(1):46\u201350.","journal-title":"Diabetes Res Clin Pract"},{"key":"732_CR36","doi-asserted-by":"crossref","unstructured":"Wu J, Zhong Y, Yue S, Yang K, Zhang G, Chen L, Liu L. Aqueous humor mediator and cytokine aberrations in diabetic retinopathy and diabetic macular edema: a systematic review and meta-analysis. Dis Markers. 2019;2019:6928524.","DOI":"10.1155\/2019\/6928524"},{"key":"732_CR37","doi-asserted-by":"crossref","unstructured":"Obad\u0103 O, Pantalon AD, Rusu-Zota G, H\u0103isan A, Lupu\u015foru SI, Constantinescu D, Chiseli\u0163\u0103 D. Aqueous humor cytokines in non-proliferative diabetic retinopathy. Medicina (Kaunas). 2022;58(7).","DOI":"10.3390\/medicina58070909"},{"key":"732_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.diabres.2017.09.002","volume":"132","author":"P Aschner","year":"2017","unstructured":"Aschner P. New IDF clinical practice recommendations for managing type 2 diabetes in primary care. Diabetes Res Clin Pract. 2017;132:169\u201370.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"732_CR39","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.2337\/dc09-0959","volume":"32","author":"S Zoungas","year":"2009","unstructured":"Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, MacMahon S, Marre M, Neal B, Patel A, et al. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care. 2009;32(11):2068\u201374.","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"732_CR40","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/dc23-S006","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, et al. 6. Glycemic targets: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S97\u2013s110.","journal-title":"Diabetes Care"},{"issue":"12","key":"732_CR41","doi-asserted-by":"publisher","first-page":"770","DOI":"10.7326\/0003-4819-152-12-201006150-00004","volume":"152","author":"DC Ziemer","year":"2010","unstructured":"Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, Narayan KM, Koch DD, Phillips LS. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152(12):770\u201377.","journal-title":"Ann Intern Med"},{"issue":"1","key":"732_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/jc.2002-020092","volume":"88","author":"SL Ferrari","year":"2003","unstructured":"Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocr Metab. 2003;88(1):255\u201359.","journal-title":"J Clin Endocr Metab"},{"issue":"12","key":"732_CR43","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nrd1901","volume":"4","author":"MK Jain","year":"2005","unstructured":"Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4(12):977\u201387.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"732_CR44","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1038\/s41598-024-81424-9","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Yang J, Liu Z, Li X. Effect of metformin on the level of aqueous humor inflammatory cytokines in patients with cataract. Sci Rep. 2025;15(1):3672.","journal-title":"Sci Rep"},{"issue":"12","key":"732_CR45","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s40618-023-02162-9","volume":"46","author":"G Bendotti","year":"2023","unstructured":"Bendotti G, Montefusco L, Pastore I, Lazzaroni E, Lunati ME, Fiorina P. The anti-inflammatory and immunological properties of SGLT-2 inhibitors. J Endocrinol Invest. 2023;46(12):2445\u201352.","journal-title":"J Endocrinol Invest"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00732-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00732-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00732-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:13:44Z","timestamp":1781612024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-025-00732-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00732-y","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Article updated to include an additional funding source in the funding section.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and approved by the Peking University Third Hospital Ethics Committee (2025-033-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent forms for their participation in the study and publication of their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}